Scienture Holdings (SCNX) Research & Development (2021 - 2026)

Scienture Holdings has disclosed Research & Development across 6 years of filings, most recently posting $793984.0 for Q1 2026.

• Research & Development for Q1 2026 came in at $793984.0, up 1188.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 19.67% YoY), and the FY2025 annual result was $2.0 million, down 12.54% from the prior year.
• Research & Development came in at $793984.0 for Q1 2026 at Scienture Holdings, down from $1.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $1.9 million in Q4 2024 to a low of $9756.0 in Q3 2025.
• The 5-year median for Research & Development is $86674.0 (2024), against an average of $364139.9.
• Across the five-year window, Research & Development soared 7561.35% in 2024 and sank 93.8% in 2025, its largest moves.
• Scienture Holdings' Research & Development stood at $302310.0 in 2022, then tumbled by 91.62% to $25334.0 in 2023, then jumped by 7561.35% to $1.9 million in 2024, then declined by 3.99% to $1.9 million in 2025, then slumped by 57.39% to $793984.0 in 2026.
• The last three Research & Development figures came in at $793984.0 (Q1 2026), $1.9 million (Q4 2025), and $9756.0 (Q3 2025), per Business Quant data.